1 Result(s)

Article

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?

Carfilzomib (Cfz) has been associated with an ~5% incidence of unexplained and unpredictable cardiovascular toxicity in clinical trials. We therefore implemented a detailed, prospective, clinical cardiac and r...

A Rosenthal, J Luthi, M Belohlavek, K M Kortüm, F Mookadam, A Mayo… in Blood Cancer Journal (2016)